No systemic reactions to influenza vaccination in egg-sensitized tertiary-care pediatric patients

<p>Abstract</p> <p>Background</p> <p>There are numerous, disparate guidelines for influenza vaccination in egg-allergic patients. We aimed to describe the outcome of selectively applied guidelines, based on risk-stratification, to our high risk, egg-allergic, tertiary-c...

Full description

Bibliographic Details
Main Authors: Upton Julia, Hummel David, Kasprzak Anna, Atkinson Adelle
Format: Article
Language:English
Published: BMC 2012-03-01
Series:Allergy, Asthma & Clinical Immunology
Subjects:
Online Access:http://www.aacijournal.com/content/8/1/2
_version_ 1818370317607763968
author Upton Julia
Hummel David
Kasprzak Anna
Atkinson Adelle
author_facet Upton Julia
Hummel David
Kasprzak Anna
Atkinson Adelle
author_sort Upton Julia
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>There are numerous, disparate guidelines for influenza vaccination in egg-allergic patients. We aimed to describe the outcome of selectively applied guidelines, based on risk-stratification, to our high risk, egg-allergic, tertiary-care pediatric population.</p> <p>Methods</p> <p>Egg allergy was confirmed with skin testing. The vaccine administered was an adjuvunated 2009 H1N1 influenza A vaccine with < 0.165 mcg/ml ovalbumin. Patients with mild egg allergy were to receive the vaccination in 1 dose, those with severe egg allergy were to receive 2 split doses, and patients with exquisite egg allergy or significant co-morbidities were to be skin tested with the vaccine (prick full strength, intradermal 1:100 of final concentration without adjuvant) and had 5 step desensitization if the testing was positive, or 1-2 step administration if negative. Patients were observed for 60 minutes after the final dose and anaphylaxis treatment was available. We report the frequency of allergic reactions.</p> <p>Results</p> <p>Ninety-nine patients were referred and 79 had positive egg testing. Asthma was present in 67% and 30% had prior anaphylaxis to egg. We vaccinated 77 of 79 patients: 71 without performing vaccine skin testing. Two refused vaccination. No patient had a systemic reaction or required treatment. Two patients experienced positive testing to the adjuvanated intradermal vaccine, but were negative without adjuvant.</p> <p>Conclusions</p> <p>Our results suggest that most egg-allergic tertiary care pediatric patients can be vaccinated with a low ovalbumin content influenza vaccine without prior vaccine testing. Vaccine skin testing, if used at all, can be reserved for special circumstances. The squalene adjuvant may cause an irritant reaction with intradermal testing.</p>
first_indexed 2024-12-13T23:37:49Z
format Article
id doaj.art-2943abf288274f38ae13141a494546ee
institution Directory Open Access Journal
issn 1710-1484
1710-1492
language English
last_indexed 2024-12-13T23:37:49Z
publishDate 2012-03-01
publisher BMC
record_format Article
series Allergy, Asthma & Clinical Immunology
spelling doaj.art-2943abf288274f38ae13141a494546ee2022-12-21T23:27:15ZengBMCAllergy, Asthma & Clinical Immunology1710-14841710-14922012-03-0181210.1186/1710-1492-8-2No systemic reactions to influenza vaccination in egg-sensitized tertiary-care pediatric patientsUpton JuliaHummel DavidKasprzak AnnaAtkinson Adelle<p>Abstract</p> <p>Background</p> <p>There are numerous, disparate guidelines for influenza vaccination in egg-allergic patients. We aimed to describe the outcome of selectively applied guidelines, based on risk-stratification, to our high risk, egg-allergic, tertiary-care pediatric population.</p> <p>Methods</p> <p>Egg allergy was confirmed with skin testing. The vaccine administered was an adjuvunated 2009 H1N1 influenza A vaccine with < 0.165 mcg/ml ovalbumin. Patients with mild egg allergy were to receive the vaccination in 1 dose, those with severe egg allergy were to receive 2 split doses, and patients with exquisite egg allergy or significant co-morbidities were to be skin tested with the vaccine (prick full strength, intradermal 1:100 of final concentration without adjuvant) and had 5 step desensitization if the testing was positive, or 1-2 step administration if negative. Patients were observed for 60 minutes after the final dose and anaphylaxis treatment was available. We report the frequency of allergic reactions.</p> <p>Results</p> <p>Ninety-nine patients were referred and 79 had positive egg testing. Asthma was present in 67% and 30% had prior anaphylaxis to egg. We vaccinated 77 of 79 patients: 71 without performing vaccine skin testing. Two refused vaccination. No patient had a systemic reaction or required treatment. Two patients experienced positive testing to the adjuvanated intradermal vaccine, but were negative without adjuvant.</p> <p>Conclusions</p> <p>Our results suggest that most egg-allergic tertiary care pediatric patients can be vaccinated with a low ovalbumin content influenza vaccine without prior vaccine testing. Vaccine skin testing, if used at all, can be reserved for special circumstances. The squalene adjuvant may cause an irritant reaction with intradermal testing.</p>http://www.aacijournal.com/content/8/1/2egg allergyvaccinationinfluenza virusadjuvantsqualene
spellingShingle Upton Julia
Hummel David
Kasprzak Anna
Atkinson Adelle
No systemic reactions to influenza vaccination in egg-sensitized tertiary-care pediatric patients
Allergy, Asthma & Clinical Immunology
egg allergy
vaccination
influenza virus
adjuvant
squalene
title No systemic reactions to influenza vaccination in egg-sensitized tertiary-care pediatric patients
title_full No systemic reactions to influenza vaccination in egg-sensitized tertiary-care pediatric patients
title_fullStr No systemic reactions to influenza vaccination in egg-sensitized tertiary-care pediatric patients
title_full_unstemmed No systemic reactions to influenza vaccination in egg-sensitized tertiary-care pediatric patients
title_short No systemic reactions to influenza vaccination in egg-sensitized tertiary-care pediatric patients
title_sort no systemic reactions to influenza vaccination in egg sensitized tertiary care pediatric patients
topic egg allergy
vaccination
influenza virus
adjuvant
squalene
url http://www.aacijournal.com/content/8/1/2
work_keys_str_mv AT uptonjulia nosystemicreactionstoinfluenzavaccinationineggsensitizedtertiarycarepediatricpatients
AT hummeldavid nosystemicreactionstoinfluenzavaccinationineggsensitizedtertiarycarepediatricpatients
AT kasprzakanna nosystemicreactionstoinfluenzavaccinationineggsensitizedtertiarycarepediatricpatients
AT atkinsonadelle nosystemicreactionstoinfluenzavaccinationineggsensitizedtertiarycarepediatricpatients